Velmetia er en kombination af to antihyperglykæmiske præparater med komplementære virkningsmekanismer til forbedring af glykæmisk kontrol hos patienter med type 2- diabetes: sitagliptinphosphat, en dipeptylpeptidase- 4- hæmmer (DPP- 4), og metforminhydrochlorid, der tilhører biguanidklassen.
24 Velmetia combines two antihyperglycaemic agents with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: sitagliptin phosphate, a dipeptidyl peptidase 4 (DPP-4) inhibitor, and metformin hydrochloride, a member of the biguanide class.